Garetosmab

TARRYTOWN, N.Y., August 19, 2026 Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved...

TARRYTOWN, N.Y., June 4, 2026 Regeneron Pharmaceuticals has unveiled a broad slate of new clinical and preclinical research across...

Rare Disease Biologic Advances Toward U.S. Approval – February 19, 2026 | Tarrytown, New York Regeneron Pharmaceuticals announced that...